University College London
About
The UCL Technology Fund (UCLTF) is an early-stage venture capital fund co-managed by AlbionVC and UCL Business (UCLB). It invests in intellectual property commercialization opportunities arising from UCL's research base, primarily in engineering and life sciences, with the aim of generating significant societal and market impact. The fund supports projects from proof-of-concept to spinout companies, with investments ranging from early-stage proof-of-concept funding to larger spinout investments.
Key facts
- Website
- ucltf.co.uk
- Headquarters
- London, United Kingdom
- Stages
- Pre-SeedSeedSeries A
- Cheque size
- $2M to $3M
- Sector focus
- AIBiomedical ScienceLife SciencesPhysical SciencesEngineering
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 23 Jan 2024 | NRG Therapeutics | Undisclosed round | $2M |
| 24 Jan 2023 | NRG Therapeutics | Undisclosed round | $2M |
| 25 Jan 2022 | NRG Therapeutics | Undisclosed round | $2M |
| 26 Jan 2021 | NRG Therapeutics | Undisclosed round | $2M |
| 28 Jan 2020 | NRG Therapeutics | Undisclosed round | $3M |
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Write the first review
Frequently asked
What companies has University College London invested in?
University College London has invested in NRG Therapeutics.
SEC filings, insider activity, nonprofit links and pay benchmarks for University College London:
